Malattia di Wilson (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Malattia di Wilson" in Italian language version.

refsWebsite

Global rank Italian rank

25nih.gov

4^th place

9^th place

23doi.org

2^nd place

7^th place

12oadoi.org

799^th place

22^nd place

3archive.org

6^th place

8^th place

3web.archive.org

1^st place

2oxfordjournals.org

1,389^th place

732^nd place

2bmj.com

1,226^th place

928^th place

2wiley.com

222^nd place

243^rd place

1osservatoriomalattierare.it

low place

5,863^rd place

1telethon.it

low place

7,350^th place

1ama-assn.org

3,257^th place

5,565^th place

1ebmonline.org

low place

1dystonia-europe.org

low place

1jamanetwork.com

2,650^th place

2,089^th place

1books.google.com

3^rd place

14^th place

1rarediseases.org

5,181^st place

low place

1gastrojournal.org

low place

1nature.com

234^th place

226^th place

1jhep-elsevier.com

low place

ama-assn.org

archneur.ama-assn.org

Robertson WM, Wilson's disease, in Arch. Neurol., vol. 57, n. 2, febbraio 2000, pp. 276–7, DOI:10.1001/archneur.57.2.276, PMID 10681092.

archive.org

Vilensky JA, Robertson WM, Gilman S, Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]), in Neurology, vol. 59, n. 6, settembre 2002, pp. 914–6, PMID 12297577.
Harper PL, Walshe JM, Reversible pancytopenia secondary to treatment with tetrathiomolybdate, in Br. J. Haematol., vol. 64, n. 4, dicembre 1986, pp. 851–3, DOI:10.1111/j.1365-2141.1986.tb02250.x, PMID 3801328.
Walshe JM, Treatment of Wilson's disease: the historical background, in QJM, vol. 89, n. 7, luglio 1996, pp. 553–5, PMID 8759497.

bmj.com

gut.bmj.com

Merle U, Schaefer M, Ferenci P, Stremmel W, Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study, in Gut, vol. 56, n. 1, 2007, pp. 115–20, DOI:10.1136/gut.2005.087262, PMC 1856673, PMID 16709660.

jmg.bmj.com

de Bie P, Muller P, Wijmenga C, Klomp LW, Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes, in J. Med. Genet., vol. 44, n. 11, novembre 2007, pp. 673–88, DOI:10.1136/jmg.2007.052746, PMC 2752173, PMID 17717039.

books.google.com

Gaetano Crepaldi e Aldo Baritussio, Trattato di medicina interna, PICCIN, 2002, pp. 4687–, ISBN 978-88-299-1642-9. URL consultato il 27 agosto 2011.

doi.org

dx.doi.org

Kinnier Wilson SA, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver (PDF), in Brain, vol. 34, n. 1, 1912, pp. 295–507, DOI:10.1093/brain/34.4.295.
Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397–408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
Robertson WM, Wilson's disease, in Arch. Neurol., vol. 57, n. 2, febbraio 2000, pp. 276–7, DOI:10.1001/archneur.57.2.276, PMID 10681092.
Cumings JN, The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration (PDF), in Brain, vol. 71, Dec, 1948, pp. 410–5, DOI:10.1093/brain/71.4.410, PMID 18124738.
McIntyre N, Clink HM, Levi AJ, Cumings JN, Sherlock S, Hemolytic anemia in Wilson's disease, in N. Engl. J. Med., vol. 276, n. 8, febbraio 1967, pp. 439–44, DOI:10.1056/NEJM196702232760804, PMID 6018274.
Cumings JN, The effects of B.A.L. in hepatolenticular degeneration, in Brain, vol. 74, n. 1, marzo 1951, pp. 10–22, DOI:10.1093/brain/74.1.10, PMID 14830662.
Denny-Brown D, Porter H, The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease), in N. Engl. J. Med., vol. 245, n. 24, dicembre 1951, pp. 917–25, DOI:10.1056/NEJM195112132452401, PMID 14882450.
Walshe JM, Wilson's disease; new oral therapy, in Lancet, vol. 267, n. 6906, gennaio 1956, pp. 25–6, DOI:10.1016/S0140-6736(56)91859-1, PMID 13279157.
Walshe JM, Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride, in Lancet, vol. 1, n. 8273, marzo 1982, pp. 643–7, DOI:10.1016/S0140-6736(82)92201-2, PMID 6121964.
Harper PL, Walshe JM, Reversible pancytopenia secondary to treatment with tetrathiomolybdate, in Br. J. Haematol., vol. 64, n. 4, dicembre 1986, pp. 851–3, DOI:10.1111/j.1365-2141.1986.tb02250.x, PMID 3801328.
Brewer GJ, Recognition, diagnosis, and management of Wilson's disease, in Proc. Soc. Exp. Biol. Med., vol. 223, n. 1, gennaio 2000, pp. 39–46, DOI:10.1046/j.1525-1373.2000.22305.x, PMID 10632959.
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW, The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 327–37, DOI:10.1038/ng1293-327, PMID 8298639.
Tanzi RE, Petrukhin K, Chernov I, et al., The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 344–50, DOI:10.1038/ng1293-344, PMID 8298641.
Merle U, Schaefer M, Ferenci P, Stremmel W, Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study, in Gut, vol. 56, n. 1, 2007, pp. 115–20, DOI:10.1136/gut.2005.087262, PMC 1856673, PMID 16709660.
Lorincz MT, Neurologic Wilson's disease, in Annals of the New York Academy of Sciences, vol. 1184, 2010, pp. 173–87, DOI:10.1111/j.1749-6632.2009.05109.x, PMID 20146697.
Roberto Erro, Ignacio Rubio-Agusti e Tabish A. Saifee, Rest and other types of tremor in adult-onset primary dystonia, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 85, n. 9, 1º settembre 2014, pp. 965–968, DOI:10.1136/jnnp-2013-305876. URL consultato il 29 novembre 2016.
de Bie P, Muller P, Wijmenga C, Klomp LW, Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes, in J. Med. Genet., vol. 44, n. 11, novembre 2007, pp. 673–88, DOI:10.1136/jmg.2007.052746, PMC 2752173, PMID 17717039.
Grubenbecher S, Stüve O, Hefter H, Korth C, Prion protein gene codon 129 modulates clinical course of neurological Wilson disease, in Neuroreport, vol. 17, n. 5, 2006, pp. 549–52, DOI:10.1097/01.wnr.0000209006.48105.90, PMID 16543824.
Roberts EA, Schilsky ML, A practice guideline on Wilson disease (PDF) ^{[collegamento interrotto]}, in Hepatology, vol. 37, n. 6, 2003, pp. 1475–92, DOI:10.1053/jhep.2003.50252, PMID 12774027.
Shaver WA, Bhatt H, Combes B, Low serum alkaline phosphatase activity in Wilson's disease, in Hepatology, vol. 6, n. 5, 1986, pp. 859–63, DOI:10.1002/hep.1840060509, PMID 3758940.
Hisao Hayashi, Motoyoshi Yano, Yoshikazu Fujita, Shinya Wakusawa, Compound overload of copper and iron in patients with Wilson's disease, in Medical Molecular Morphology, vol. 39, 2006, pp. 121–126, DOI:10.1007/s00795-006-0326-7, PMID 16998622.
Das SK, Ray K, Wilson's disease: an update, in Nat Clin Pract Neurol, vol. 2, n. 9, settembre 2006, pp. 482–93, DOI:10.1038/ncpneuro0291, PMID 16932613.
Brewer GJ, Askari FK, Wilson's disease: clinical management and therapy, in Journal of Hepatology, vol. 42, Suppl 1, 2005, pp. 13–21, DOI:10.1016/j.jhep.2004.11.013, PMID 15777568.

dystonia-europe.org

(EN) Dystonia - Dystonia Europe, in Dystonia Europe. URL consultato il 30 novembre 2016.

ebmonline.org

Brewer GJ, Recognition, diagnosis, and management of Wilson's disease, in Proc. Soc. Exp. Biol. Med., vol. 223, n. 1, gennaio 2000, pp. 39–46, DOI:10.1046/j.1525-1373.2000.22305.x, PMID 10632959.

gastrojournal.org

Jonathan D. Gitlina, Wilson disease - Clinical presentation, Journal of Gastroenterology

jamanetwork.com

Keun-Hwa Jung, MD; Tae-Beom Ahn, MD; Beom S. Jeon, MD, PhD, Wilson Disease With an Initial Manifestation of Polyneuropathy, Jama Neurology

jhep-elsevier.com

Brewer GJ, Askari FK, Wilson's disease: clinical management and therapy, in Journal of Hepatology, vol. 42, Suppl 1, 2005, pp. 13–21, DOI:10.1016/j.jhep.2004.11.013, PMID 15777568.

nature.com

Das SK, Ray K, Wilson's disease: an update, in Nat Clin Pract Neurol, vol. 2, n. 9, settembre 2006, pp. 482–93, DOI:10.1038/ncpneuro0291, PMID 16932613.

nih.gov

ncbi.nlm.nih.gov

WB. Hu, YZ. Han; BC. Xue; N. Cheng; DY. Sun; DQ. Ye; RM. Yang, [Epidemiological study of hepatolenticular degeneration at Hanshan County, Anhui Province]., in Zhonghua Yi Xue Za Zhi, vol. 91, n. 13, aprile 2011, pp. 894-7, PMID 21600116.
Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397–408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
Robertson WM, Wilson's disease, in Arch. Neurol., vol. 57, n. 2, febbraio 2000, pp. 276–7, DOI:10.1001/archneur.57.2.276, PMID 10681092.
Cumings JN, The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration (PDF), in Brain, vol. 71, Dec, 1948, pp. 410–5, DOI:10.1093/brain/71.4.410, PMID 18124738.
McIntyre N, Clink HM, Levi AJ, Cumings JN, Sherlock S, Hemolytic anemia in Wilson's disease, in N. Engl. J. Med., vol. 276, n. 8, febbraio 1967, pp. 439–44, DOI:10.1056/NEJM196702232760804, PMID 6018274.
Cumings JN, The effects of B.A.L. in hepatolenticular degeneration, in Brain, vol. 74, n. 1, marzo 1951, pp. 10–22, DOI:10.1093/brain/74.1.10, PMID 14830662.
Denny-Brown D, Porter H, The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease), in N. Engl. J. Med., vol. 245, n. 24, dicembre 1951, pp. 917–25, DOI:10.1056/NEJM195112132452401, PMID 14882450.
Vilensky JA, Robertson WM, Gilman S, Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol]), in Neurology, vol. 59, n. 6, settembre 2002, pp. 914–6, PMID 12297577.
Walshe JM, Wilson's disease; new oral therapy, in Lancet, vol. 267, n. 6906, gennaio 1956, pp. 25–6, DOI:10.1016/S0140-6736(56)91859-1, PMID 13279157.
Walshe JM, Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride, in Lancet, vol. 1, n. 8273, marzo 1982, pp. 643–7, DOI:10.1016/S0140-6736(82)92201-2, PMID 6121964.
Harper PL, Walshe JM, Reversible pancytopenia secondary to treatment with tetrathiomolybdate, in Br. J. Haematol., vol. 64, n. 4, dicembre 1986, pp. 851–3, DOI:10.1111/j.1365-2141.1986.tb02250.x, PMID 3801328.
Walshe JM, Treatment of Wilson's disease: the historical background, in QJM, vol. 89, n. 7, luglio 1996, pp. 553–5, PMID 8759497.
Brewer GJ, Recognition, diagnosis, and management of Wilson's disease, in Proc. Soc. Exp. Biol. Med., vol. 223, n. 1, gennaio 2000, pp. 39–46, DOI:10.1046/j.1525-1373.2000.22305.x, PMID 10632959.
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW, The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 327–37, DOI:10.1038/ng1293-327, PMID 8298639.
Tanzi RE, Petrukhin K, Chernov I, et al., The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 344–50, DOI:10.1038/ng1293-344, PMID 8298641.
Merle U, Schaefer M, Ferenci P, Stremmel W, Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study, in Gut, vol. 56, n. 1, 2007, pp. 115–20, DOI:10.1136/gut.2005.087262, PMC 1856673, PMID 16709660.
Lorincz MT, Neurologic Wilson's disease, in Annals of the New York Academy of Sciences, vol. 1184, 2010, pp. 173–87, DOI:10.1111/j.1749-6632.2009.05109.x, PMID 20146697.
Roberto Erro, Ignacio Rubio-Agusti e Tabish A. Saifee, Rest and other types of tremor in adult-onset primary dystonia, in Journal of Neurology, Neurosurgery, and Psychiatry, vol. 85, n. 9, 1º settembre 2014, pp. 965–968, DOI:10.1136/jnnp-2013-305876. URL consultato il 29 novembre 2016.
de Bie P, Muller P, Wijmenga C, Klomp LW, Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes, in J. Med. Genet., vol. 44, n. 11, novembre 2007, pp. 673–88, DOI:10.1136/jmg.2007.052746, PMC 2752173, PMID 17717039.
Grubenbecher S, Stüve O, Hefter H, Korth C, Prion protein gene codon 129 modulates clinical course of neurological Wilson disease, in Neuroreport, vol. 17, n. 5, 2006, pp. 549–52, DOI:10.1097/01.wnr.0000209006.48105.90, PMID 16543824.
Roberts EA, Schilsky ML, A practice guideline on Wilson disease (PDF) ^{[collegamento interrotto]}, in Hepatology, vol. 37, n. 6, 2003, pp. 1475–92, DOI:10.1053/jhep.2003.50252, PMID 12774027.
Shaver WA, Bhatt H, Combes B, Low serum alkaline phosphatase activity in Wilson's disease, in Hepatology, vol. 6, n. 5, 1986, pp. 859–63, DOI:10.1002/hep.1840060509, PMID 3758940.
Hisao Hayashi, Motoyoshi Yano, Yoshikazu Fujita, Shinya Wakusawa, Compound overload of copper and iron in patients with Wilson's disease, in Medical Molecular Morphology, vol. 39, 2006, pp. 121–126, DOI:10.1007/s00795-006-0326-7, PMID 16998622.
Das SK, Ray K, Wilson's disease: an update, in Nat Clin Pract Neurol, vol. 2, n. 9, settembre 2006, pp. 482–93, DOI:10.1038/ncpneuro0291, PMID 16932613.
Brewer GJ, Askari FK, Wilson's disease: clinical management and therapy, in Journal of Hepatology, vol. 42, Suppl 1, 2005, pp. 13–21, DOI:10.1016/j.jhep.2004.11.013, PMID 15777568.

oadoi.org

Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML, Wilson's disease, in Lancet, vol. 369, n. 9559, 2007, pp. 397–408, DOI:10.1016/S0140-6736(07)60196-2, PMID 17276780.
McIntyre N, Clink HM, Levi AJ, Cumings JN, Sherlock S, Hemolytic anemia in Wilson's disease, in N. Engl. J. Med., vol. 276, n. 8, febbraio 1967, pp. 439–44, DOI:10.1056/NEJM196702232760804, PMID 6018274.
Cumings JN, The effects of B.A.L. in hepatolenticular degeneration, in Brain, vol. 74, n. 1, marzo 1951, pp. 10–22, DOI:10.1093/brain/74.1.10, PMID 14830662.
Denny-Brown D, Porter H, The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease), in N. Engl. J. Med., vol. 245, n. 24, dicembre 1951, pp. 917–25, DOI:10.1056/NEJM195112132452401, PMID 14882450.
Walshe JM, Wilson's disease; new oral therapy, in Lancet, vol. 267, n. 6906, gennaio 1956, pp. 25–6, DOI:10.1016/S0140-6736(56)91859-1, PMID 13279157.
Walshe JM, Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride, in Lancet, vol. 1, n. 8273, marzo 1982, pp. 643–7, DOI:10.1016/S0140-6736(82)92201-2, PMID 6121964.
Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW, The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 327–37, DOI:10.1038/ng1293-327, PMID 8298639.
Tanzi RE, Petrukhin K, Chernov I, et al., The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene, in Nat. Genet., vol. 5, n. 4, 1993, pp. 344–50, DOI:10.1038/ng1293-344, PMID 8298641.
Lorincz MT, Neurologic Wilson's disease, in Annals of the New York Academy of Sciences, vol. 1184, 2010, pp. 173–87, DOI:10.1111/j.1749-6632.2009.05109.x, PMID 20146697.
Grubenbecher S, Stüve O, Hefter H, Korth C, Prion protein gene codon 129 modulates clinical course of neurological Wilson disease, in Neuroreport, vol. 17, n. 5, 2006, pp. 549–52, DOI:10.1097/01.wnr.0000209006.48105.90, PMID 16543824.
Shaver WA, Bhatt H, Combes B, Low serum alkaline phosphatase activity in Wilson's disease, in Hepatology, vol. 6, n. 5, 1986, pp. 859–63, DOI:10.1002/hep.1840060509, PMID 3758940.
Hisao Hayashi, Motoyoshi Yano, Yoshikazu Fujita, Shinya Wakusawa, Compound overload of copper and iron in patients with Wilson's disease, in Medical Molecular Morphology, vol. 39, 2006, pp. 121–126, DOI:10.1007/s00795-006-0326-7, PMID 16998622.

osservatoriomalattierare.it

Malattia di Wilson su Osservatorio malattie rare

oxfordjournals.org

brain.oxfordjournals.org

Kinnier Wilson SA, Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver (PDF), in Brain, vol. 34, n. 1, 1912, pp. 295–507, DOI:10.1093/brain/34.4.295.
Cumings JN, The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration (PDF), in Brain, vol. 71, Dec, 1948, pp. 410–5, DOI:10.1093/brain/71.4.410, PMID 18124738.

rarediseases.org

Wilson Disease - Rare Disease

telethon.it

Malattia di Wilson - Fondazione Telethon

web.archive.org

La Malattia - Associazione Nazionale Malattia di Wilson ONLUS, su malattiadiwilson.org. URL consultato il 27 maggio 2019 (archiviato dall'url originale il 27 maggio 2019).
MANAGEMENT OF PATIENT WITH HEPATOLIENAL SYNDROME - MANAGEMENT OF PATIENT WITH PORTAL HYPERTENSION - MANAGEMENT OF PATIENT WITH ASCITES, su intranet.tdmu.edu.ua. URL consultato il 28 maggio 2019 (archiviato dall'url originale il 14 maggio 2019).
Definitions - Wilson's Disease Association, su wilsonsdisease.org. URL consultato il 28 maggio 2019 (archiviato dall'url originale il 28 maggio 2019).

wiley.com

onlinelibrary.wiley.com

M. C. Trindade, T. Bittencourt, G. Lorenzi‐Filho, R. C. Alves, D. C. de Andrade, E. T. Fonoff, E. Bor‐Seng‐Shu, A. A. Machado, M. J. Teixeira, E. R. Barbosa, G. G. Tribl, Restless legs syndrome in Wilson's disease: frequency, characteristics, and mimics, Acta neurologica scandinavica

www3.interscience.wiley.com

Roberts EA, Schilsky ML, A practice guideline on Wilson disease (PDF) ^{[collegamento interrotto]}, in Hepatology, vol. 37, n. 6, 2003, pp. 1475–92, DOI:10.1053/jhep.2003.50252, PMID 12774027.